The role of adjuvant immunomodulatory agents for treatment of severe influenza
- 8 January 2018
- journal article
- review article
- Published by Elsevier BV in Antiviral Research
- Vol. 150, 202-216
- https://doi.org/10.1016/j.antiviral.2018.01.002
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute, National Institutes of Health (HHSN261200800001E)
This publication has 158 references indexed in Scilit:
- Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09Journal of Clinical Virology, 2013
- Azithromycin and the Risk of Cardiovascular DeathThe New England Journal of Medicine, 2012
- Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate StudyThe Journal of Infectious Diseases, 2011
- The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a γδ T cell population in humanized miceThe Journal of Experimental Medicine, 2011
- A Parametric Study on the Immunomodulatory Effects of Electroacupuncture in DNP-KLH Immunized MiceEvidence-Based Complementary and Alternative Medicine, 2011
- Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus InfectionThe New England Journal of Medicine, 2010
- Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational LevelOnline Journal of Public Health Informatics, 2009
- TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infectionProceedings of the National Academy of Sciences of the United States of America, 2009
- Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virusProceedings of the National Academy of Sciences of the United States of America, 2008
- Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic MechanismsNature Reviews Drug Discovery, 2005